spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  diclofenac 

 HSMN NewsFeed - 6 Apr 2020
Perrigo Announces FDA Approval for the Store Brand Equivalent of Voltaren(R) Arthritis Pain
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 Oct 2019
Zyla Life Sciences Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jun 2019
Zyla Life Sciences Appoints Dr. H. Jeffrey Wilkins as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2019
Perrigo Announces FDA Final Approval For AB Rated Generic Version Of Voltaren(R) Gel 1%
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 27 Nov 2018
Perrigo Launches Its AB Rated Generic Version of Solaraze(R) Gel 3%
Biopharmaceuticals Generics Dermatology Product Launch
 HSMN NewsFeed - 31 Oct 2018
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 Aug 2018
Nuvo Pharmaceuticals(TM) Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 23 Jul 2018
Lannett Announces Multiple Product Launches
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 7 May 2018
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 15 May 2017
Nuvo Pharmaceuticals(TM) Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid(R) 2%
Biopharmaceuticals
 HSMN NewsFeed - 28 Mar 2017
Nuvo Pharmaceuticals(TM) Enters into Pennsaid(R) 2% License Agreement with Sayre Therapeutics PVT Ltd. for India, Sri Lanka, Bangladesh and Nepal
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Apr 2016
Nuvo Pharmaceuticals(TM) Inc. Announces Appointment of Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2015
Depomed Files New Patent Infringement Lawsuit Against NUCYNTA(R) ER ANDA Filer
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 13 Apr 2015
Depomed Announces Gralise(R) ANDA Litigation Settlement Confirming Exclusivity to 2024 and Dismissing Appeal
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 10 Apr 2015
Horizon Pharma plc Receives FDA Fast Track Designation for ACTIMMUNE(R) in the Treatment of Friedreich's Ataxia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 30 Mar 2015
Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per Share or $1.1 Billion in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Feb 2015
Horizon Pharma plc Submits Investigational New Drug Application for ACTIMMUNE(R) in the Treatment of Friedreich's Ataxia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 13 Nov 2014
Nuvo Research(R) reacquires Pennsaid(R) 2% rights to South America, Central America, South Africa and Israel
Biopharmaceuticals Distribution
 HSMN NewsFeed - 13 Jan 2014
Insys Announces Details of Product Development Pipeline
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 3 Jan 2014
Iroko’s ZORVOLEX(TM) Now Available
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 21 Nov 2013
Impax Laboratories Launches Generic Solaraze(R) (Diclofenac Sodium Gel, 3%)
Biopharmaceuticals Generics Dermatology Product Launch
 HSMN NewsFeed - 27 Aug 2012
Depomed Licenses Acuform(R) Patents to Janssen Pharmaceuticals, Inc.
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 8 Nov 2011
Nautilus Neurosciences Appoints Peter Lankau as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2011
Cara Therapeutics Announces Appointment of James B. Jones, M.D., Pharm.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2010
Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions Litigation
 HSMN NewsFeed - 13 Apr 2010
Galen Partners Invests in Nautilus Neurosciences, Inc.
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 18 Dec 2009
Myriad Pharmaceuticals to Acquire Javelin Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Oct 2009
Transdel Pharmaceuticals Appoints Dr. Joachim P.H. Schupp as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jun 2009
Xanodyne Receives Approval From the U.S. Food and Drug Administration for ZIPSOR(TM) (diclofenac potassium) Liquid Filled Capsules
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Jun 2009
Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 19 Feb 2009
FDA Accepts Nuvo's Resubmission For Pennsaid(R)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 22 Sep 2008
Alpharma to Develop and Commercialize DURECT's ELADUR(TM) Pain Patch
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 31 Jul 2008
Javelin Pharmaceuticals and Baxter Healthcare Corporation Expand Commercial Supply Relationship for Anticipated Dyloject(TM) Global Growth
Biopharmaceuticals
 HSMN NewsFeed - 22 Jul 2008
Xanodyne Receives Approvable Letter From the U.S. Food and Drug Administration for ZIPSOR(TM) (diclofenac potassium) Capsules
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Jun 2008
Alpharma Announces Changes to Executive Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 May 2008
Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 24 Apr 2008
Transdel Pharmaceuticals Appoints Chief Medical Officer and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Apr 2008
Alpharma to Withdraw and Resubmit Its New Drug Application for EMBEDA(TM)
Biopharmaceuticals
 HSMN NewsFeed - 18 Apr 2008
Akorn, Inc. Announces FDA Approval of Diclofenac Sodium Ophthalmic Solution 0.1%
BIopharmaceuticals Generics Ophthalmology FDA
 HSMN NewsFeed - 10 Mar 2008
Javelin Pharmaceuticals' Dyloject Accepted by Scottish Medicines Consortium (SMC)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Mar 2008
Javelin Pharmaceuticals Board Appoints Industry Veteran Martin Driscoll as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Feb 2008
Alpharma Submits New Drug Application for EMBEDA(TM)
Biopharmaceuticals
 HSMN NewsFeed - 6 Feb 2008
Alpharma Announces the Sale of Its Active Pharmaceutical Ingredients Business to 3i for $395 Million in Cash
Biopharmaceuticals Acquisitions Venture Capital
 HSMN NewsFeed - 4 Jan 2008
Cerimon Pharmaceuticals Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2008
Pharmos Corporation Announces Board and Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2007
Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2007
Javelin Pharmaceuticals Announces Successful Dyloject Pivotal US Phase 3 Trial Top-Line Results at New York City Analyst Day
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2007
Javelin Pharmaceuticals Launches Dyloject(R) in UK
Biopharmaceuticals
 HSMN NewsFeed - 12 Nov 2007
ISTA Pharmaceuticals Presents Results from Two Phase III Clinical Trials of Xibrom(TM) QD (Once-daily) Formulation at the American Academy of Ophthalmology Annual Meeting
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 31 Oct 2007
Javelin Pharmaceuticals Receives Marketing Authorization Approval for Dyloject(R) in the United Kingdom
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Oct 2007
Pharmos Restructures Operations in Israel
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2007
Alpharma Appoints John J. Howarth as Vice President, Investor Relations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Oct 2007
Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
Biopharmaceuticals Pain Management FDA
 HSMN NewsFeed - 12 Oct 2007
Alpharma Closes Transaction to License U.S. Rights for Prescription Topical NSAID Pain Drug
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 8 Oct 2007
Shire Divests Non-Core Product Portfolio to Almirall
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 26 Jul 2007
Javelin Pharmaceuticals Begins Second Phase 3 Study of Dyloject(TM)
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2007
Javelin Pharmaceuticals Signs Commercial Supply Agreement with Baxter Healthcare Corporation
Biopharmaceuticals
 HSMN NewsFeed - 12 Apr 2007
FDA Advisory Committee Recommends Against Approval for Merck's NDA for ARCOXIA(R) (etoricoxib)
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Mar 2007
Nuvo announces further update on discussions with the FDA related to review of Pennsaid
Biopharmaceuticals
 HSMN NewsFeed - 27 Feb 2007
American Heart Association Scientific Statement: AHA Statement Recommends Doctors Change Approach to Prescribing Pain Relievers for Patients With or at Risk for Heart Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 9 Jan 2007
Akorn, Inc. Signs Exclusive Definitive Agreement For the Development and Supply of Three Ophthalmic ANDA Drug Products
Biopharmaceuticals Ophthalmology Generics
 HSMN NewsFeed - 8 Jan 2007
ProEthic Pharmaceuticals Announces Positive Phase III Clinical Trial Results for Fast-Acting Migraine Product Candidate
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2007
Cerimon Pharmaceuticals Names Daniel Levitt, M.D., Ph.D. Executive Vice President of Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Dec 2006
Nuvo receives approvable letter from U.S. FDA for Pennsaid
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Dec 2006
Cerimon Pharmaceuticals Names Ayse Kocak Vice President of Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2006
Large Outcomes Study Showed Merck's ARCOXIA(R) (etoricoxib) had Similar Rates of Cardiovascular Thrombotic Events Compared to Diclofenac, the Most Prescribed Traditional NSAID Worldwide
Biopharmaceuticals
 HSMN NewsFeed - 10 Nov 2006
Merck Responds to FDA-Issued Approvable Letters for Arcoxia(R) (etoricoxib)
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Sep 2006
Cerimon Pharmaceuticals Names Timothy J. McBride as Senior Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2006
Javelin Pharmaceuticals, Inc. To Present Final Analysis of Phase 2b Study Results of Dyloject(TM) at Prestigious European Pain Conference - September 14, 2006
Biopharmaceuticals
 HSMN NewsFeed - 14 Jul 2006
Nuvo's Pennsaid NDA Resubmission Accepted for Review by U.S. FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 May 2006
ProEthic Pharmaceuticals Initiates Pivotal Phase III Trial for Fast-Acting Migraine Product Candidate
Biopharmaceuticals
 HSMN NewsFeed - 4 May 2006
ISTA Pharmaceuticals(R) Announces Study Indicating Twice-Daily Dosing of Xibrom(TM) as Equivalent to Four Times a Day of Other Treatments
Biopharmaceuticals Ophthalmology
Return to NewsFeed  

 Additional items found! 29

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 29 additional stories matching:
diclofenac
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.